Jilin Province Huinan Changlong Bio-pharmacy Co Ltd
HKEX:8049
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
J
|
Jilin Province Huinan Changlong Bio-pharmacy Co Ltd
HKEX:8049
|
CN |
|
Yowie Group Ltd
ASX:YOW
|
AU |
|
Tourism Holdings Ltd
NZX:THL
|
NZ |
|
Nile Ltd
BSE:530129
|
IN |
|
Fairchem Organics Ltd
NSE:FAIRCHEMOR
|
IN |
|
Taiwan Mask Corp
TWSE:2338
|
TW |
|
E
|
Edwards Lifesciences Corp
BMV:EW
|
US |
|
Orapi SA
PAR:ORAP
|
FR |
|
C
|
CopperCorp Resources Inc
XTSX:CPER
|
CA |
|
aTyr Pharma Inc
NASDAQ:ATYR
|
US |
|
O
|
Oisix Ra Daichi Inc
TSE:3182
|
JP |
|
Korro Bio Inc
NASDAQ:KRRO
|
US |
|
Generation Income Properties Inc
NASDAQ:GIPR
|
US |
|
Reclaims Global Ltd
SGX:NEX
|
SG |
|
C
|
China Starch Holdings Ltd
HKEX:3838
|
HK |
|
U
|
Unifiedpost Group SA
XBRU:UPG
|
BE |
Bankruptcy Probability
Jilin Province Huinan Changlong Bio-pharmacy Co Ltd's probability of bankruptcy is hidden . The solvency score is hidden .
We take all the information about a company's solvency (such as how easily a company can pay interest on its outstanding debt, how much cash it has, the amount of debt, and more) and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Jilin Province Huinan Changlong Bio-pharmacy Co Ltd Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| CN |
J
|
Jilin Province Huinan Changlong Bio-pharmacy Co Ltd
HKEX:8049
|
1.3B HKD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Eli Lilly and Co
NYSE:LLY
|
837.7B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Johnson & Johnson
NYSE:JNJ
|
583.9B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CH |
|
Roche Holding AG
SIX:ROG
|
248.4B CHF |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| UK |
|
AstraZeneca PLC
LSE:AZN
|
228B GBP |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Merck & Co Inc
NYSE:MRK
|
292.3B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CH |
|
Novartis AG
SIX:NOVN
|
229.9B CHF |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
237.1B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Pfizer Inc
NYSE:PFE
|
157.9B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1T DKK |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Bristol-Myers Squibb Co
NYSE:BMY
|
120.2B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Jilin Province Huinan Changlong Bio-pharmacy Co Ltd's probability of bankruptcy is hidden .
The probability of bankruptcy is estimated using credit risk models that assess its financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Jilin Province Huinan Changlong Bio-pharmacy Co Ltd has no debt.
You can find a full breakdown on its Balance Sheet.
